INTRODUCTION
At latitudes above 408N, vitamin D is not synthesized in the skin during the winter (1) and therefore, the vitamin D supply during this period depends on dietary intakes. Relatively few foods contain vitamin D (2) naturally, and vitamin D intakes are lower than dietary recommendations in most populations (3-5). Consequently, vitamin D deficiency is a public health concern in many countries (6) (7) (8) (9) (10) .
The recently updated American dietary reference values for vitamin D from the Institute of Medicine (11) have stimulated scientific debate about the effects of different strategies to improve vitamin D status, which is measured as circulating 25- 
hydroxyvitamin D [25(OH)D]
4 concentrations (12) , at the population level. Food fortification is one preventive strategy to reach the entire population, and several countries fortify milk or margarine with vitamin D. Nonetheless, this fortification practice does not seem optimal for improving vitamin D status in the general population because of the skewness of milk intake across population groups (13, 14) . A recently published systematic review emphasized the need for randomized controlled trials (RCTs) to ascertain the impact of potential vitamin D food-fortification strategies to ensure effectiveness at the population level (15) . In Denmark, there are few fortified foods on the market, and thus, this country provides a unique opportunity to investigate the effects of a fortification strategy in a real-life environment.
Previous RCTs have investigated the effects of single vitamin D-fortified foods such as milk (16) (17) (18) (19) (20) (21) (22) (23) (24) , yoghurt drink (25, 26) , cheese (27, 28) , orange juice (29, 30) , and bread (31) . In all but 2 of these RCTs (24, 27) , the foods were shown to be effective in improving serum 25(OH)D concentrations. However, to reach the entire population, a strategy has been suggested (32) in which several food vehicles are fortified at lower amounts rather than one food item at a higher fortification amount. To our knowledge, no previous studies have investigated combinations of fortified foods, and only a few studies have targeted children (19, 22) .
Our strategy was to build a realistic fortification model that could be used in a real-life setting on the basis of models generated from high-quality dietary intake data from the Danish National Survey of Dietary Habits and Physical Activity (33) .
The objective of this RCT was to investigate the effects of increasing vitamin D intake by fortification of milk and bread to the amount recommended in the Nordic Nutrition Recommendations (NNRs) (34) on serum 25(OH)D concentration in families during a 6-mo winter period in Denmark.
SUBJECTS AND METHODS

Study design
The study was a double-blind, randomized, placebo-controlled intervention trial with children and adults recruited as families. An external statistician randomly allocated the families to either vitamin D 3 -fortified milk and bread or nonfortified placebo milk and bread for 6 mo during the winter (September 2010 to April 2011). Milk and bread were distributed to the families 2 times/ wk through 3 local supermarkets. The random allocation was stratified by the number of female and male children and adults in the family, use of multivitamin supplements, distribution supermarket, and week of blood sampling by using the minimization method (35) . The milk and bread were blinded by a color and letter code so that neither the participants nor researchers knew which products contained vitamin D. A personal identification card informed each family which supermarket to go to and obtain products. The card ensured that families received the correct products and that products were handed out only to families who were participating in the study. Participants were instructed to replace their usual consumption of milk and bread with the products provided in the study. In all other respects, participants were requested to live their lives as normal without changing any habits. The principle in the study design was to investigate a realistic fortification strategy in a real-life setting. Adult participants were seen 3 times during the study period (months 0, 3, and 6), and children (4-17 y old) were seen twice (months 0 and 6). Blood samples were drawn at all 3 visits, and anthropometric measures were recorded at months 0 and 6. The primary endpoint was the serum 25(OH)D concentration, and secondary endpoints were plasma parathyroid hormone (PTH) and serum total calcium.
The study protocol was approved by the Research Ethics Committee of the Capital Region of Denmark (record H-4-2010-020).
Participants
The sample size was calculated at 88 per group to detect a mean (6SD) difference in serum 25(OH)D concentration of 11 6 26 nmol/L (21) between treatment groups at the 5% significance level and with 80% power. To be able to analyze female and male children and adults separately and allow for dropouts, we aimed to recruit 800 participants who represented w200 families. Participants were recruited in Gladsaxe Municipality in Denmark (568N) by random withdrawal from the Danish Civil Registration System. Families with a permanent address in Gladsaxe and 3-6 members in the household, including at least one child aged 4-17 y, were invited by letter to participate in the study (Figure 1) . Inclusion criteria were age between 4 and 60 y and a permanent address in the Gladsaxe Municipality. Exclusion criteria were pregnancy and disease or use of a medication that would influence vitamin D metabolism (including dietary supplements with .10 mg vitamin D/d for children and .5 mg vitamin D/d for adults, which corresponded to the typical amounts in multivitamin supplements in Denmark). There was an ample response to the letters, and registration was closed after 10 d. At that time, 429 families had responded to the invitation. After screening for eligibility, 230 families were selected, and invited to an information meeting. When the families hereafter decided on their participation, not all members of the household necessarily participated. All adult participants and custody holders of children gave their written informed consent to participate, which resulted in a total of 782 participants (201 families).
Fortification model
The fortification model was built on the following 3 criteria: the model should include a combination of foods, foods should be consumed regularly in the chosen age group, and foods should be low in fat and sugar. On the basis of these criteria, milk and bread were chosen as foods to include in the model. The fortification strategy was to increase the vitamin D intake to 7.5 mg/d as recommended in the NNRs (34) in as many participants as possible while avoiding an intake above the tolerable upper intake level [ie, 25 mg/d for children and 50 mg/d for adults (34) ]. The choice of fortification amounts was based on models generated from dietary intake data from the Danish National Survey of Dietary Habits and Physical Activity (7-d consecutive dietary record) (33) , which took into account the possible use of multivitamin supplements.
Study milks were organic homogenized 0.5% fat milk produced by Arla Foods A/S. The fortified milk had a vitamin D 3 (cholecalciferol; Kemikalia) concentration w0.38 mg/100 mL, which was confirmed by analysis in triplicate during the study period (0.40 6 0.01 mg/100 mL). The placebo milk did not contain added vitamin D (,0.004 mg/100 mL). Study breads included white bread, brown bread, rye bread, and buns that were baked from wheat-and rye-flour blends produced by Lantmännen Cerealia A/S. Vitamin D 3 (cholecalciferol; DSM Nutritional Products) was added to flour blends to bake fortified breads. Before and after the study period, samples from 3 different flour blends of both types were analyzed, and the added vitamin D was recovered. Twice during the study period, breads of each type were collected on 3 consecutive baking days and analyzed in pools of 4 breads. We aimed to produce fortified breads with 6 mg vitamin D 3 /100 g bread, but the analyses showed a concentration of 5.2 6 0.3 mg vitamin D 3 /100 g in the wheat bread and 4.3 6 0.3 mg vitamin D 3 /100 g in the rye bread. The placebo bread did not contain added vitamin D. Concentrations of vitamin D in study milks and breads were analyzed at the National Food Institute, Technical University of Denmark, by using a reversephase HPLC method described elsewhere (36) . Analyses were accredited according to the standard ISO 17025 (37) .
Dietary assessment and compliance
At baseline (month 0), participants completed a self-administered Web-based questionnaire that assessed their background, health, and lifestyle and a semi-quantitative food-frequency questionnaire EFFECTS OF VITAMIN D FORTIFICATION (FFQ) that assessed their vitamin D and calcium intakes before the study. The FFQ was adapted from an FFQ used in the European Union project Towards a strategy for Optimal Vitamin D Fortification (38) . By the end of the study (month 6), questionnaires were repeated to assess eventual changes in health or lifestyle and vitamin D and calcium intakes during the study. The 2 FFQs were also used to evaluate if participants changed their consumption of milk and bread during the study.
Vitamin D and calcium intakes from the habitual diet were calculated on the basis of consumption frequencies and vitamin D and calcium concentrations in food items given in the Danish Food Composition Databank (39) . Vitamin D contributions from the fortified milk and bread were calculated on the basis of frequencies of milk and bread consumptions and measured vitamin D concentrations in the study milk and bread.
Compliance to the intervention was registered 4 times during the study. In a short self-administered Web-based questionnaire, participants reported their consumption of milk and bread other than the products provided in the study. Compliance was estimated by dividing the number of portions of milk or bread consumed per day other than the products provided in the study by the total number of portions of milk or bread consumed per day as reported in the FFQ.
Examination and blood collection
Participants were examined, and blood samples were collected, in an authorized laboratory (Copenhagens General Practitioners Laboratory). Weight was measured to the nearest 0.1 kg in normal clothes without shoes (1 kg was withdrawn from the measured weight) by using a body-composition analyzer (Tanita BC-418; Tanita Europe BV). Height was measured to the nearest centimeter without shoes by using an ultrasonic height measure (Soehnle 5001; Soehnle Professional GmbH & Co). BMI (in kg/m 2 ) was calculated on the basis of measured weight and height, and participants were categorized into normal weight, overweight, and obese classes according to standards for children (40) and the WHO International standard for adults (41) . Local anesthetic patches were offered to the children before blood sampling. A trained biomedical laboratory technician drew nonfasting venous blood samples from participants. Blood samples were held at room temperature for 30 min before centrifugation (1800 3 g for 10 min), and serum and plasma were collected and stored at 2808C until analysis.
Biochemical analyses
All blood samples were analyzed as single determinations in a random order at the Clinical Biochemical Department, Holbaek Hospital, Holbaek, Denmark, after completion of the study. Measurements of serum 25(OH)D relied on the determination of both 25(OH)D 2 and 25(OH)D 3 and were conducted by isotopedilution liquid chromatography-tandem mass spectrometry by using principles described elsewhere (42) . The standard reference material vitamin D in human serum (SRM 972) from the National Institute of Standards and Technology (43) was used as the primary calibrator. The analytic quality of the 25(OH)D assay was assured by Vitamin D External Quality Assessment Scheme certification. In this validation scheme, the mean bias for our method compared with the mean of the Vitamin D External Quality Assessment Scheme liquid chromatographymass spectrometry group during the period of the present analyses was 23.2%. Interassay CVs for our method were 2.2% and 2.8% at 30 and 180 nmol/L, respectively, for 25(OH)D 3 and 7.6% and 4.6% at 43 and 150 nmol/L, respectively, for 25(OH)D 2 . Serum total calcium (CV: 1.2%) was measured by using a chemistry analyzer Cobas c501 (Roche Diagnostics), and plasma PTH (CV: 3.4%) was measured by using an immunology analyzer Cobas e601 (Roche Diagnostics) following standard procedures from the manufacturer.
Statistical analyses
Statistical analyses were conducted with participants who completed the study and from whom baseline and final biochemical data were obtained (Figure 1 ). Data were analyzed with SPSS statistical software (version 20.0; IBM SPSS Inc), and statistical significance was determined at P , 0.05. Intakes are presented as medians (IQRs) and biochemical measures as geometric means (IQRs) unless otherwise stated. Linear mixed models with the family as a random factor were applied in the following analyses to account for the nonindependency of the participants. All continuous variables were log transformed before analysis to meet model requirements. Eventual changes in milk and bread consumptions during the study period were evaluated by testing the difference between the 2 registered consumptions (months 0 and 6) against the null hypothesis. Likewise, in children and adults separately, differences in biochemical measures [25(OH)D, PTH, and total calcium) between months 0, 3, and 6 within treatment groups were tested against the null hypothesis to determine eventual changes. Linear trend analyses for serum 25(OH)D in adults were applied. Treatment groups (children and adults separately) were compared for biochemical measures at the different time points in mixed models with the group as a categorical variable and serum 25(OH)D as the dependent variable. Treatment effects on biochemical endpoints were tested in mixed models adjusted for age and sex (categorical variables) and for baseline values of the endpoint (covariate). A second model with the primary endpoint 25(OH)D was further adjusted for BMI, multivitamin usage, and sun vacation to evaluate the potential influence on the treatment effect. Interactions between the group and baseline, group and sex, and group and age were assessed in the model with 25(OH)D as the endpoint. Binary logistic regression by using the generalized estimating equation (to allow for dependence within families) was applied to compare treatment groups in their prevalence of serum 25(OH)D concentrations ,30 and ,50 nmol/L at baseline (month 0) and at the end of the study (month 6).
RESULTS
Characteristics and intakes of participants
Of a total of 201 families (782 participants), 6 families (20 participants) and 28 single participants did not complete the study for various reasons (Figure 1 ). An additional 8 participants were excluded from the final analysis because of insufficient blood collection. Baseline characteristics and intakes are shown in Table 1 .
Neither milk nor the bread consumption changed during the study (data not shown; P = 0.551 for milk and P = 0.580 for bread). Daily median (IQR) milk consumptions were 532 mL (262, 712 mL) in children and 266 mL (139,
In the fortification group, 78% of children and 56% of adults (average for children and adults: 66%) reached the vitamin Dintake goal of 7.5 mg/d. By comparison, only 2% in the control group had a vitamin D intake $7.5 mg/d. None of the participants exceeded the tolerable upper intake level.
Approximately 90% of participant total intake of milk and bread was the study milk and bread (Table 1) . Primary reasons for participants drinking or eating other foods than study products were children having school milk or eating in the day care center and adults eating in the canteen at work. Table 2 ). The combined analysis of children and adults with the primary linear mixed model, which was adjusted for baseline 25(OH)D, sex, and age, showed a treatment effect on the serum 25(OH)D concentration (P , 0.001) so that the final 25(OH)D was estimated to be 59% higher in the fortification group than in the control group. Additional adjustment of the model for BMI, multivitamin usage, and sun vacation did not change the magnitude of the effect of treatment (Table 3) . No interaction effects were observed between group and baseline serum 25(OH)D (P = 0.080), group and age (P = 0.082), or group and sex (P = 0.317).
Biochemical measures
In the adult fortification group, 25(OH)D decreased from months 0 to 3 (P , 0.001) and increased from months 3 to 6 (P = 0.014); nevertheless, the final concentration was lower than the baseline concentration (P , 0.001). In the adult control group, 25(OH)D decreased from months 0 to 3 (P , 0.001) and continued decreasing from months 3 to 6 (P = 0.001). There was a linear trend for the serum 25(OH)D concentration in adults in both treatment groups (both P-trend , 0.001). In children, 25(OH)D decreased from months 0 to 6 in both the fortification and control groups (both P , 0.001) ( Table 2) .
At baseline, ,1% of participants had a 25(OH)D concentration ,30 nmol/L, and 8-9% of participants had a 25(OH)D concentration ,50 nmol/L with no differences between treatment groups in their prevalence (P = 0.158 for ,30 nmol/L and P = 0.814 for ,50 nmol/L). By the end of the study, ,1% of subjects in the fortification group compared with 25% of subjects in the control group had 25(OH)D concentrations ,30 nmol/L (P , 0.001), and 16% of subjects in the fortification group compared with 65% of subjects in the control group had 25(OH)D concentrations ,50 nmol/L (P , 0.001) (Figure 2) .
PTH and total calcium did not change during the study in the fortification group (PTH: P = 0.099 for children and P = 0.156 for adults; calcium: P = 0.799 for children and P = 0.321 for adults). By contrast, PTH increased and total calcium decreased in the control group (PTH: P , 0.001 for both children and adults; calcium: P = 0.041 for children and P = 0.001 for adults) ( Table 2) .
The final PTH concentration was lower in the fortification group than in the control group in both children and adults, whereas there was no difference in final total calcium concentrations between treatment groups ( Table 2 ). The combined analysis of children and adults in linear mixed models adjusted for baseline values of the endpoint, sex, and age showed a treatment effect on PTH (P , 0.001) so that the final PTH was estimated to be 9% lower in the fortification group than in the control group. There was no treatment effect on total calcium (P = 0.237).
DISCUSSION
The fortification strategy in the current study resulted in a higher serum 25(OH)D concentration in the fortification group (67.6 nmol/L) than in the control group (41.7 nmol/L) at the end of the winter season, despite the fact that 25(OH)D decreased in both treatment groups during the study (2D5.5 nmol/L in the fortification group and 2D29.4 nmol/L in the control group). The planned fortification strategy was to increase the vitamin D intake to the amount of 7.5 mg/d recommended in the NNRs (34) . This strategy succeeded in 78% of children and 56% of the adults in the fortification group. As a result of the increased intake, 84% of subjects in the fortification group had 1 BMI categorization based on standards for children (40) and the WHO International standard for adults (41) . 2 Intakes during the study. Sample sizes: n = 146 in the children fortification group and n = 162 in the control group and n = 185 in the adult fortification group and n = 195 in the control group.
3 Median; IQR in parentheses (all such values). 4 Percentage of total milk and bread consumptions that come from study products. Sample sizes: for milk compliance, n = 130 in the children fortification group and n = 156 in the control group and n = 166 in the adult fortification group and n = 183 in the control group; for bread compliance: n = 140 in the children fortification group and n = 156 in the control group and n = 179 in the adult fortification group and n = 191 in the control group.
5 Supplement usage and vacation in places where dermal vitamin D production was expected during the study. Sample sizes: n = 148 in the children fortification group and n = 163 in the control group and n = 187 in the adult fortification group and n = 195 in the control group. a serum 25(OH)D concentration .50 nmol/L by the end of the study.
The recently updated American Recommended Dietary Allowance for vitamin D was set at 15 mg/d by the Institute of Medicine (11) . This value was estimated to ensure a target serum 25(OH)D concentration of 50 nmol/L under conditions of minimal exposure to the sun, such as under the circumstances in the current study. The target value of 50 nmol/L was considered to cover the requirement of the majority of the population in relation to the optimal calcium absorption and related bone health. 1 All values are geometric means; IQRs in parentheses. P values are for the comparison of treatment groups in biochemical measures at each time point with linear mixed models with family as a random factor, group as a categorical variable, and the logarithm of the biochemical measure as the dependent variable. Significant change within treatment groups analyzed in mixed models with family as a random factor and the difference between the logarithm of the biochemical measure at time points of interest as the dependent variable: from month 0, *P , 0.05, **P # 0.001; from month 3, y P , 0.05, yy P # 0.001. (15) . This value is considerably lower than our result. It is to be noted that a higher percentage of our participants compared with those in the meta-analysis studies reported multivitamin supplement use and sun vacation during the study. Furthermore, our study had a relatively high mean baseline 25(OH)D and a relatively low fortification amount, and the beneficial effect was expressed as a reduction in the seasonal decline in 25(OH)D compared with in the control group. Our observations were similar to those of 2 other RCTs in 17-54-y-old men and women with baseline 25(OH)D and fortification amounts comparable to those in our study (18, 21) . These studies showed treatment effects of w2 nmol $ L 21 $ mg 21 . Most studies had a lower initial starting point than that of our study and observed an increase in 25(OH)D after supplementation with vitamin D-fortified foods (16, 17, 19, 20, 22, 23, 25, 26, (28) (29) (30) (31) . An important conclusion from the meta-analysis (15) and a systematic review by the NIH (45) was the large heterogeneity between fortification studies. The studies varied in design, study population, baseline 25(OH)D, foodvehicle used, and fortification amounts. Therefore, the treatment effects could not be directly compared and should be interpreted with caution.
P-linear
To our knowledge, a novelty in the design of the current study was the combined use of 2 food vehicles consumed during the day according to the participantsusual habits. This design was different from that in other randomized studies that used the effects of single vitamin D-fortified foods consumed in a predefined serving or amount. It has been shown that the efficiency of vitamin D in fortified foods to improve serum 25(OH)D concentrations is equal to that of dietary supplements (22, 28, 29, 31) , and daily dosing with supplements was shown to be more efficient than seasonal dosing in maintaining 25(OH)D (22) . Therefore, we consider that the larger treatment effect observed in the current study compared with in other fortification studies suggested that the response to vitamin D fortification in circulating 25(OH)D also depends on the daily frequency of ingestion.
One of the strengths of this study was the family and real-life based design, which we believe was one of the main reasons for the low dropout rate and high compliance. Informal feedback from participants indicated that they made their participation a joint family project, which they could discuss at dinner times, and they encouraged and reminded one another to consume the study products provided. It is important to consider this compliance aspect in the design of future studies. The family-based design also ensured a broad spread of age and sex in both children and adults. Another strength was the use of a specific analytic method to measure serum 25(OH)D concentrations.
An important finding was that the analyses of bread did not fully recover all of the added vitamin D. We suspect that some of the vitamin D was lost during baking. This loss was unexpected because, in a previous fortification study, the added vitamin D was recovered in both dough and baked wheat and rye breads (31) . This issue should be further investigated.
A minor drawback of the study was that the study population may not have been fully representative of the general population in Denmark. It is possible that the response to the fortification would have been different in other population groups such as elderly or dark-skinned groups. This possibility should be investigated in the future. However, if implementation of the fortification strategy was mandatory, the use of fortified products would not depend on the consumers deliberate choice, which could be influenced by factors such as age, sex, education, social status, and ethnic affiliation.
This study showed that it is feasible to conduct RCTs in real-life settings without compromising the treatment effect. Furthermore, we showed the use of model data from usual food-consumption intakes to establish an effective fortification strategy targeted at the intended population. The combination of fortified milk and bread proved suitable for 4-60-y-old Danes, partly because Danish children and, to some extent, adults drink more milk than do other population groups. Milk is not widely consumed in all populations, whereas bread is a primary food in many countries. Therefore, this study suggested that including bread in the current selection of vitamin D-fortified foods could be an effective way to attenuate seasonal fluctuations in vitamin D status.
In conclusion, vitamin D fortification of milk and bread, to an amount that increased the intake to recommended amount, reduced the decrease in serum 25(OH)D concentrations during winter and ensured 25(OH)D concentrations .50 nmol/L in children and adults in Denmark.
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